SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-109400
Filing Date
2015-03-27
Accepted
2015-03-27 16:08:35
Documents
3
Period of Report
2015-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d900048d8k.htm 8-K 26511
2 EX-4.1 d900048dex41.htm EX-4.1 905160
3 EX-4.2 d900048dex42.htm EX-4.2 137494
  Complete submission text file 0001193125-15-109400.txt   1070514
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 15731034
SIC: 2834 Pharmaceutical Preparations